Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.

Mice and rats were tested for reduced sensitivity to cocaine-induced hyper-locomotion after pretreatment with anti-cocaine antibody or cocaine hydrolase (CocH) derived from human butyrylcholinesterase (BChE). In Balb/c mice, direct i.p. injection of CocH protein (1 mg/kg) had no effect on spontaneou...

Full description

Bibliographic Details
Main Authors: Marilyn E Carroll, Natalie E Zlebnik, Justin J Anker, Thomas R Kosten, Frank M Orson, Xiaoyun Shen, Berma Kinsey, Robin J Parks, Yang Gao, Stephen Brimijoin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3422258?pdf=render
_version_ 1819132237563559936
author Marilyn E Carroll
Natalie E Zlebnik
Justin J Anker
Thomas R Kosten
Frank M Orson
Xiaoyun Shen
Berma Kinsey
Robin J Parks
Yang Gao
Stephen Brimijoin
author_facet Marilyn E Carroll
Natalie E Zlebnik
Justin J Anker
Thomas R Kosten
Frank M Orson
Xiaoyun Shen
Berma Kinsey
Robin J Parks
Yang Gao
Stephen Brimijoin
author_sort Marilyn E Carroll
collection DOAJ
description Mice and rats were tested for reduced sensitivity to cocaine-induced hyper-locomotion after pretreatment with anti-cocaine antibody or cocaine hydrolase (CocH) derived from human butyrylcholinesterase (BChE). In Balb/c mice, direct i.p. injection of CocH protein (1 mg/kg) had no effect on spontaneous locomotion, but it suppressed responses to i.p. cocaine up to 80 mg/kg. When CocH was injected i.p. along with a murine cocaine antiserum that also did not affect spontaneous locomotion, there was no response to any cocaine dose. This suppression of locomotor activity required active enzyme, as it was lost after pretreatment with iso-OMPA, a selective BChE inhibitor. Comparable results were obtained in rats that developed high levels of CocH by gene transfer with helper-dependent adenoviral vector, and/or high levels of anti-cocaine antibody by vaccination with norcocaine hapten conjugated to keyhole limpet hemocyanin (KLH). After these treatments, rats were subjected to a locomotor sensitization paradigm involving a "training phase" with an initial i.p. saline injection on day 1 followed by 8 days of repeated cocaine injections (10 mg/kg, i.p.). A 15-day rest period then ensued, followed by a final "challenge" cocaine injection. As in mice, the individual treatment interventions reduced cocaine-stimulated hyperactivity to a modest extent, while combined treatment produced a greater reduction during all phases of testing compared to control rats (with only saline pretreatment). Overall, the present results strongly support the view that anti-cocaine vaccine and cocaine hydrolase vector treatments together provide enhanced protection against the stimulatory actions of cocaine in rodents. A similar combination therapy in human cocaine users might provide a robust therapy to help maintain abstinence.
first_indexed 2024-12-22T09:28:13Z
format Article
id doaj.art-3f9b485801a24cc18b5905678ff7ad7a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T09:28:13Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-3f9b485801a24cc18b5905678ff7ad7a2022-12-21T18:31:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4353610.1371/journal.pone.0043536Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.Marilyn E CarrollNatalie E ZlebnikJustin J AnkerThomas R KostenFrank M OrsonXiaoyun ShenBerma KinseyRobin J ParksYang GaoStephen BrimijoinMice and rats were tested for reduced sensitivity to cocaine-induced hyper-locomotion after pretreatment with anti-cocaine antibody or cocaine hydrolase (CocH) derived from human butyrylcholinesterase (BChE). In Balb/c mice, direct i.p. injection of CocH protein (1 mg/kg) had no effect on spontaneous locomotion, but it suppressed responses to i.p. cocaine up to 80 mg/kg. When CocH was injected i.p. along with a murine cocaine antiserum that also did not affect spontaneous locomotion, there was no response to any cocaine dose. This suppression of locomotor activity required active enzyme, as it was lost after pretreatment with iso-OMPA, a selective BChE inhibitor. Comparable results were obtained in rats that developed high levels of CocH by gene transfer with helper-dependent adenoviral vector, and/or high levels of anti-cocaine antibody by vaccination with norcocaine hapten conjugated to keyhole limpet hemocyanin (KLH). After these treatments, rats were subjected to a locomotor sensitization paradigm involving a "training phase" with an initial i.p. saline injection on day 1 followed by 8 days of repeated cocaine injections (10 mg/kg, i.p.). A 15-day rest period then ensued, followed by a final "challenge" cocaine injection. As in mice, the individual treatment interventions reduced cocaine-stimulated hyperactivity to a modest extent, while combined treatment produced a greater reduction during all phases of testing compared to control rats (with only saline pretreatment). Overall, the present results strongly support the view that anti-cocaine vaccine and cocaine hydrolase vector treatments together provide enhanced protection against the stimulatory actions of cocaine in rodents. A similar combination therapy in human cocaine users might provide a robust therapy to help maintain abstinence.http://europepmc.org/articles/PMC3422258?pdf=render
spellingShingle Marilyn E Carroll
Natalie E Zlebnik
Justin J Anker
Thomas R Kosten
Frank M Orson
Xiaoyun Shen
Berma Kinsey
Robin J Parks
Yang Gao
Stephen Brimijoin
Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.
PLoS ONE
title Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.
title_full Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.
title_fullStr Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.
title_full_unstemmed Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.
title_short Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.
title_sort combined cocaine hydrolase gene transfer and anti cocaine vaccine synergistically block cocaine induced locomotion
url http://europepmc.org/articles/PMC3422258?pdf=render
work_keys_str_mv AT marilynecarroll combinedcocainehydrolasegenetransferandanticocainevaccinesynergisticallyblockcocaineinducedlocomotion
AT natalieezlebnik combinedcocainehydrolasegenetransferandanticocainevaccinesynergisticallyblockcocaineinducedlocomotion
AT justinjanker combinedcocainehydrolasegenetransferandanticocainevaccinesynergisticallyblockcocaineinducedlocomotion
AT thomasrkosten combinedcocainehydrolasegenetransferandanticocainevaccinesynergisticallyblockcocaineinducedlocomotion
AT frankmorson combinedcocainehydrolasegenetransferandanticocainevaccinesynergisticallyblockcocaineinducedlocomotion
AT xiaoyunshen combinedcocainehydrolasegenetransferandanticocainevaccinesynergisticallyblockcocaineinducedlocomotion
AT bermakinsey combinedcocainehydrolasegenetransferandanticocainevaccinesynergisticallyblockcocaineinducedlocomotion
AT robinjparks combinedcocainehydrolasegenetransferandanticocainevaccinesynergisticallyblockcocaineinducedlocomotion
AT yanggao combinedcocainehydrolasegenetransferandanticocainevaccinesynergisticallyblockcocaineinducedlocomotion
AT stephenbrimijoin combinedcocainehydrolasegenetransferandanticocainevaccinesynergisticallyblockcocaineinducedlocomotion